The effect of rimonabant treatment on cardiovascular risk factors in renal transplant recipients -- pilot safety study

Trial Profile

The effect of rimonabant treatment on cardiovascular risk factors in renal transplant recipients -- pilot safety study

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Dec 2014

At a glance

  • Drugs Rimonabant (Primary) ; Ciclosporin; Tacrolimus
  • Indications Cardiovascular disorders; Obesity; Renal transplant rejection
  • Focus Pharmacokinetics
  • Acronyms RIMONA-PILOT
  • Most Recent Events

    • 09 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 13 Sep 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top